Analysts Set Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Price Target at $12.38
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) has been given a consensus rating of “Buy” by the five analysts that are presently covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1-year target […]
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) has been given a consensus rating of “Buy” by the five analysts that are presently covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1-year target […]
